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There are just five black African 
clinical research scientists with a strong 
publication record in South Africa − 
part of an ageing, shrinking and grossly 
under-funded academic cadre that 
creates the ongoing knowledge so vital to 
handle our debilitating epidemics.
That is according to Professor Bongani 
Mayosi, Head of the Department of 
Medicine at the University of Cape Town 
(UCT), and Chief Specialist at Groote 
Schuur Hospital. Mayosi helped convene 
a workshop of the country’s top health 
science educators to brainstorm curricular 
mechanisms to address the overall paucity 
and advise government. Speaking during 
the 15 July workshop, aimed at increasing 
both the quality and quantity of PhDs 
in the clinical sciences at South African 
and African medical schools, Mayosi said 
that while the principle of centralised 
funding of academic health complexes 
had finally been accepted by the Minister 
of Health,1 clinical research funding 
remained an alarmingly low government 
priority. ‘South Africa is a predominantly 
black country. That we have five or less 
black African clinician scientists with a 
strong record of published papers – in 
other words real scholars – is pretty bad. 
Why? Well, we’ve simply not invested in 
producing them. The future of our country 
rests on the way we address this,’ he said.
Font of knowledge creation 
drying up
Mayosi said less than 1% of all health care 
professionals in the country had a PhD as an 
addition to their professional degree, which 
meant that the crucible of South Africa’s 
knowledge creation had insufficient capacity 
to help stem the regression of life expectancy 
to 1955 levels (from 70 years old in 1990 to 
50 currently). This percentage of leaders, 
teachers and innovators were trained in how 
to create knowledge (as against using it), an 
aspect that had long been sorely neglected.
Mayosi described the Academic Medicine 
Project as like a ‘holy trinity’, with three 
joint, inseparable components. ‘You have 
to have a clinical service upon which you 
are teaching and training doctors and 
nurses (two legs), but you also need to 
be producing new knowledge. We had a 
(provincial) funding governance mechanism 
that put health academia in no-man’s land.1 
That has now been solved − at least in 
principle − by the acceptance of the need for 
central governance and funding of academic 
health complexes (as originally envisaged in 
the National Health Act of 2003). But the 
second problem is that, while there is clear 
funding for the health service and increasing 
money for clinical training, there is minimal 
funding for health research – so the overall 
holy trinity is being deprived of nutrition!’
A central aim of the country’s top health 
educators is to cost the funding of health 
research so that academics in teaching 
hospitals are not just employed and paid 
by the relevant hospital but by a central 
authority so they can practise, teach and do 
research. 
UCT leading the way – but 
campus co-operation vital
Professor Arieh Katz of the Division of 
Medical Biochemistry at UCT’s Medical 
School said his campus was leading the 
way in producing clinical researchers by the 
introduction of research degree programmes 
(MB ChB/BSc (Med) Honours and MB 
ChB/PhD) to medical students in parallel 
with their medical studies. According to 
Mayosi, these programmes would provide 
a sustainable training conduit for cadres 
of young clinicians/scientists that would 
revitalise and increase clinical research 
capacity. He warned however that unless 
universities worked together instead of 
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devising their own degrees in silo fashion 
there would be little chance of achieving 
equity between campuses. Mayosi and 
Katz are spearheading the initiative and 
have received the UCT Vice-Chancellor’s 
Strategic Fund Award to provide ‘pump 
priming’ for the initiative until 2013. A 
working committee from the workshop will 
be drafting a funding proposal that embraces 
the Wellcome Trust and other funders, and 
distils all contributions to achieve long-
term goals and actually change current 
government policy. 
Ms Glaudina Loots, Director of Health 
Innovation in the Department of Science 
and Technology, said the recommendations 
of a 13-member study panel appointed by 
the Council of the Academy of Science of 
South Africa (ASSAf) had been approved.2 
(Many of the workshop members were part 
of the high-level panel.) ‘The strategic goal-
oriented outcomes have been discussed and 
approved across (government) portfolios, 
so we can stick our noses into different 
government departments and we’re looking 
at strategies as a result of the report,’ she 
said to chuckles in the room. An overall 
strategy would be tabled for discussion with 
the Department of Higher Education and 
Training, the Health Department and finally 
with Treasury to identify ‘gaps needing 
filling’. Conceding there was a ‘crisis’ in 
clinical research, Loots said clinical trials 
had instead taken centre stage, hogging the 
limelight while generating R2 billion per 
annum in mainly external contract research 
with extremely limited indigenous trials. 
‘This is why we need to cost and ensure we 
can afford to put young students into PhD 
programmes to revitalise indigenous clinical 
science,’ she added.
In his opening address Professor Danie 
Visser, UCT’s Deputy Vice-Chancellor, said 
fellow academics at the Karolinska Institute in 
Stockholm (which appoints the laureates for 
the Nobel Prize in Physiology or Medicine) 
confided in him a year ago that if South 
Africa were to win a Nobel prize, it would 
probably be for TB research. This highlighted 
huge existing potential which required only 
local investment ‘to hand us back the agenda 
for clinical research and establish us as world 
leaders’. The co-incidence in South Africa 
of a high burden of disease coupled with 
high expertise in research made it ‘a crime 
to ignore the possibility presented to make a 
difference in the world’.
Supervision dilemma
Professor Eric Bateman, head of UCT’s 
groundbreaking research-to-practice Lung 
Institute, warned of the ‘enormous challenge’ 
of sourcing mentors to train PhD students 
because of their low numbers and heavy 
clinical workloads.
A bibliometric analysis of research by 
Professor Michael Kahn, Research Fellow 
at Stellenbosch University’s Centre for 
Research Evaluation of Science and 
Technology, showed that South Africa’s 
overall research publication output went 
from 20 892 between 1990 and 1994 to 
33 671 between 2004 and 2008. The output 
of research papers in medicine, general and 
internal, dropped from 2 280 between 1990 
and 1994 to 1 556 between 2004 and 2008. A 
headcount of researchers in all fields stood 
at 30 000, putting South Africa at a level 
Korea was at 30 years ago. Between 1992 and 
2007 full-time researchers in South Africa’s 
business sector grew from 3 395 to 6 264, 
government (including the science councils) 
from 2 428 to 3 058, while higher education 
went from 3 631 to 3 672.
‘The message here is we’re in trouble both 
in the government and the higher education 
sectors,’ Kahn said.
He said that, in general, the policy of 
substituting black clinical researchers for 
white male clinical researchers had not 
contributed to overall growth. The total 
national output of PhDs in the natural 
sciences (including health sciences) for 
2006 stood at 518. Of those graduates, 
over 100 were ‘our cousins’ from the South 
African Development Community (SADC) 
countries. ‘When they qualify (the locally 
funded “cousins”), they take all those years of 
effort with them to Hamburg and Houston – 
this has to be the most altruistic strategy one 
could possibly design – I don’t know of any 
other country so hell bent on shooting itself 
in the foot,’ he said caustically. Harking back 
to Professor Bateman’s warning, he said the 
Department of Science and Technology was 
living a fantasy with its PhD growth target of 
500%, because that would mean increasing 
the number of supervisors by a similar 
number. ‘Sure, they know what needs to be 
done, but they haven’t thought about how,’ he 
said. The extent to which academic clinical 
hospitals were disappearing from the radar 
in publishing academic papers was alarming, 
as was the precipitous drop in the overall 
published output of clinical research. Kahn 
highlighted one positive trend however − the 
rise by 500% of publications in infectious 
diseases and related immunology, virology, 
and public health.
Professor Wieland Gevers, described by 
Mayosi as the ‘driving force’ behind the 
pivotal ASSAf  report,2 said revitalising 
clinical research was in the national interest 
and required efficient and supportive 
management and encouragement ‘at all 
levels’. A sustainable health care system 
required guidance by a critical mass of 
research-experienced clinicians and the 
continuous training of new generations of 
‘research-informed clinicians’.
The ASSAf report recommends several 
ways to address the declining size and 
increasing age of the clinical research 
workforce, plus the paucity of effective 
training programmes and unattractive 
career-pathing in the sector. It found the 
health care system unable to cope with 
the increasing demands of clinical service 
imposed by the colliding epidemics of 
infectious and non-communicable diseases. 
There was also no national plan to provide 
co-ordinated support for the training and 
development of clinical researchers, with 
grossly insufficient support for research 
professorships and training fellowships 
in clinical research. It suggests a target of 
500 PhDs in clinical research over the next 
decade, with 30 Research Chairs earmarked 
for the clinical sciences and at least one state-
funded clinical research centre for each of 
the eight academic health complexes.2 
One mechanism for shortening the PhD 
qualification time which most workshop 
participants agreed upon was to conditionally 
shorten or do away with their period of 
obligatory community service – as a PhD 
graduate contributed hugely to community 
service through the production of new 
knowledge to overcome the major health 
challenges that face the people of South Africa.
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